X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (804) 804
Publication (101) 101
Book Chapter (3) 3
Book Review (3) 3
Dissertation (2) 2
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ertapenem (718) 718
humans (437) 437
index medicus (417) 417
microbiology (297) 297
pharmacology & pharmacy (278) 278
infectious diseases (247) 247
anti-bacterial agents - pharmacology (198) 198
antibiotics (197) 197
microbial sensitivity tests (185) 185
male (182) 182
meropenem (173) 173
female (171) 171
imipenem (168) 168
anti-bacterial agents - therapeutic use (144) 144
carbapenems (143) 143
middle aged (136) 136
aged (127) 127
enterobacteriaceae (124) 124
adult (118) 118
infections (115) 115
pharmacokinetics (107) 107
escherichia-coli (102) 102
bacteria (101) 101
resistance (98) 98
carbapenems - pharmacology (95) 95
klebsiella-pneumoniae (94) 94
drug resistance (89) 89
carbapenem (85) 85
beta-lactams - pharmacology (83) 83
anti-bacterial agents - administration & dosage (81) 81
antimicrobial agents (78) 78
polycyclic compounds (78) 78
beta-lactams - therapeutic use (72) 72
carbapenemase (71) 71
e coli (71) 71
ceftriaxone (70) 70
drug resistance, bacterial (70) 70
treatment outcome (70) 70
aged, 80 and over (68) 68
antimicrobial resistance (68) 68
internal medicine (68) 68
susceptibility (66) 66
beta-lactamases - genetics (64) 64
epidemiology (64) 64
beta-lactams (63) 63
therapy (63) 63
beta-lactamases - metabolism (61) 61
hospitals (61) 61
health aspects (57) 57
anti-bacterial agents - pharmacokinetics (56) 56
klebsiella pneumoniae - drug effects (56) 56
escherichia coli - drug effects (55) 55
bacterial infections and mycoses (53) 53
klebsiella (53) 53
emergence (52) 52
infectious disease (52) 52
retrospective studies (52) 52
biochemical phenomena, metabolism, and nutrition (51) 51
enterobacteriaceae - drug effects (51) 51
escherichia coli (51) 51
infection (51) 51
klebsiella pneumoniae - isolation & purification (51) 51
analysis (50) 50
anti-bacterial agents - adverse effects (50) 50
mortality (50) 50
pneumonia (50) 50
enterobacteriaceae infections - microbiology (48) 48
minimum inhibitory concentration (48) 48
patients (48) 48
animals (47) 47
medicine (47) 47
klebsiella infections - microbiology (46) 46
carbapenems - therapeutic use (45) 45
doripenem (45) 45
research (45) 45
risk factors (45) 45
surgery (44) 44
tigecycline (44) 44
drug resistance in microorganisms (42) 42
ciprofloxacin (41) 41
escherichia coli - isolation & purification (41) 41
adolescent (40) 40
klebsiella pneumoniae - enzymology (40) 40
antibacterial agents (39) 39
bacterial infections - drug therapy (39) 39
beta lactamases (39) 39
beta-lactamase (39) 39
beta-lactamases - biosynthesis (39) 39
beta-lactams - administration & dosage (38) 38
cephalosporins (38) 38
drug therapy (38) 38
esbl (38) 38
pseudomonas-aeruginosa (38) 38
surveillance (38) 38
escherichia coli - enzymology (37) 37
imipenem - pharmacology (37) 37
klebsiella pneumoniae (37) 37
laboratories (37) 37
mk-0826 (37) 37
pathogens (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (742) 742
Spanish (26) 26
Turkish (17) 17
German (11) 11
French (8) 8
Chinese (4) 4
Czech (3) 3
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 01/2002, Volume 46, Issue 1, pp. 42 - 46
The activities of ertapenem (MK-0826) and eight other agents against a range of penicillin-susceptible and -resistant pneumococci were tested by determination... 
Ertapenem
Journal Article
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 01/2002, Volume 46, Issue 1, pp. 220 - 224
Ertapenem, imipenem, meropenem, ceftriaxone, piperacillin, piperacillin-tazobactam, clindamycin, and metronidazole were agar dilution MIC tested against 431... 
Ertapenem
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 03/2019, Volume 510, Issue 2, pp. 254 - 260
L,D-transpeptidases, widely distributed in bacteria and even in the difficult-to-treat ESKAPE pathogens, can confer antibacterial resistance against the... 
Mycobacterium tuberculosis | Ertapenem | Ldt | Antibacterial drugs | Imipenem
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 11/2019, p. 105846
The efficacy of the currently recommended first-line treatments for gonococcal infections - ceftriaxone monotherapy or ceftriaxone/azithromycin dual therapy -... 
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 10/2019, Volume 34, Issue 10, pp. 1766 - 1772
Abstract Background Previous pharmacokinetic studies demonstrated an increase in serum ertapenem concentrations with decreasing kidney function, including... 
dialysis | kidney failure | UROLOGY & NEPHROLOGY | RISK | ertapenem sodium | PHARMACODYNAMICS | extended beta lactamase (ESBL) | ertapenem | DOSAGE REGIME | TRANSPLANTATION
Journal Article
Journal of Medical Microbiology, ISSN 0022-2615, 05/2018, Volume 67, Issue 5, pp. 662 - 668
The aim of this study was to evaluate the activity of double-carbapenem combinations against OXA-48-producing clinical isolates. Double combinations of... 
Carbapenemase | Meropenem | Synergy | Ertapenem | Imipenem
Journal Article
International Journal of Dermatology, ISSN 0011-9059, 04/2019, Volume 58, Issue 4, pp. E87 - E88
Journal Article
International Journal of Dermatology, ISSN 0011-9059, 04/2019, Volume 58, Issue 4, pp. E88 - E88
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 04/2018, Volume 73, Issue 4, pp. 987 - 994
Journal Article
Journal of Maternal-Fetal and Neonatal Medicine, ISSN 1476-7058, 2019, pp. 1 - 6
Chorioamnionitis affects 1-4% of pregnancies, and patients who undergo cesarean delivery in the setting of chorioamnionitis have an increased risk of... 
Cesarean delivery | cost-effectiveness | chorioamnionitis | ertapenem
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 03/2019, Volume 510, Issue 2, pp. 254 - 260
L,D-transpeptidases, widely distributed in bacteria and even in the difficult-to-treat ESKAPE pathogens, can confer antibacterial resistance against the... 
LdtMt2 | Mycobacterium tuberculosis | Ertapenem | Antibacterial drugs | Imipenem
Journal Article
12/2010
In this study, in vitro activity of tigecycline (TIG) and ertapenem (ERT) against clinical isolates of Brucella melitensis and the effect of different media on... 
tigecycline | Brucellosis | ertapenem
Web Resource
CLINICAL MICROBIOLOGY AND INFECTION, ISSN 1198-743X, 08/2019, Volume 25, Issue 8, pp. 943 - 950
Background: Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has... 
INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | Colistin | Mortality | MICROBIOLOGY | Extensively drug-resistant | COMBINATION | Ceftazidime-avibactam | Ertapenem | Fosfomycin | GRAM-NEGATIVE BACTERIA | IMIPENEM-CILASTATIN | DOUBLE-BLIND | Clinical failure | Meropenem | Tigecycline | CRITICALLY-ILL PATIENTS | Klebsiella pneumoniae | KLEBSIELLA-PNEUMONIAE
Journal Article
ACS Medicinal Chemistry Letters, ISSN 1948-5875, 08/2013, Volume 4, Issue 8, pp. 715 - 719
Carbapenems are intravenous lifesaving hospital antibiotics. Once patients leave the hospital, they are sent home with antibiotics other than carbapenems since... 
carbapenem | ertapenem diethyl ester | intraduodenal dosing | prodrugs | antibiotics | Ertapenem | ertapenem bis-pivoxyl | ertapenem bis-lactone | CHEMISTRY, MEDICINAL | INTESTINAL-ABSORPTION MECHANISM | PHARMACOKINETICS | TEBIPENEM PIVOXIL | IN-VITRO ACTIVITY | ORAL CARBAPENEM
Journal Article
European Journal of Gastroenterology and Hepatology, ISSN 0954-691X, 01/2016, Volume 28, Issue 3, pp. 277 - 280
Journal Article
by Ueng, YF and Wang, HJ and Wu, SC and Ng, YY
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 12/2019, Volume 63, Issue 12
A change of ertapenem dosage from 500 mg daily to thrice weekly, after each hemodialysis session, can maintain the plasma concentration above 2 mg/liter and be... 
carbapenem | PHARMACOKINETICS | hemodialysis | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | pharmacokinetic | CRITICALLY-ILL PATIENTS | ertapenem
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.